A model of the economic impact of a bipolar disorder screening program in primary care

Journal of Clinical Psychiatry

Volumn 70, Issue 9, 2009, Pages 1230-1236

  Menzin, Joseph ^a   Sussman, Matthew ^a   Tafesse, Eskinder ^b   Duczakowski, Christina ^a   Neumann, Peter ^c   Friedman, Mark ^a  

^a Boston Health Economics Inc   (United States)

^b ASTRAZENECA   (United Kingdom)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DECISION MAKING; DELAYED DIAGNOSIS; HEALTH CARE COST; HEALTH STATUS; MAJOR DEPRESSION; MANAGED CARE; MOOD DISORDER; MOOD DISORDER QUESTIONNAIRE; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIST; QUESTIONNAIRE; SCREENING TEST; ADOLESCENT; ADULT; COMPARATIVE STUDY; COST CONTROL; DECISION SUPPORT SYSTEM; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH INSURANCE; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MONTE CARLO METHOD; PRIMARY HEALTH CARE; STATISTICAL MODEL; STATISTICS;

ADOLESCENT; ADULT; BIPOLAR DISORDER; COST SAVINGS; DECISION SUPPORT TECHNIQUES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC ERRORS; EARLY DIAGNOSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MANAGED CARE PROGRAMS; MASS SCREENING; MODELS, ECONOMIC; MONTE CARLO METHOD; PRIMARY HEALTH CARE; QUESTIONNAIRES;

EID: 70350442296     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04939     Document Type: Article

References (22)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543-552. PubMed doi:10.1001/archpsyc.64.5.543 (Pubitemid 46718287)
3. Akiskal HS, Bourgeois ML, Angst J, et al. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59(suppl 1):S5-S30. PubMed doi:10.1016/S0165- 0327(00)00203-2 (Pubitemid 32164448)
4. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530-537. PubMed doi:10.1001/archpsyc.59.6.530
5. Hirschfeld RM. Bipolar spectrum disorder: improving its recognition and diagnosis. J Clin Psychiatry. 2001;62(suppl 14):5-9. PubMed
6. McCombs JS, Ahn J, Tencer T, et al. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. J Affect Disord. 2007;97(1-3):171-179. PubMed doi:10.1016/j.jad.2006. 06.018 (Pubitemid 44940824)
7. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry. 2000;61(10):804-808. PubMed
8. Angst J, Gamma A, Lewinsohn P. The evolving epidemiology of bipolar disorder. World Psychiatry. 2002;1(3):146-148. PubMed
9. Wang PS, Berglund P, Olfson M, et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2005;62(6):603-613. PubMed doi:10.1001/archpsyc.62.6.603 (Pubitemid 40973435)
10. Lish JD, me-Meenan S, Whybrow PC, et al. The National Depressive and Manic- Depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31(4):281-294. PubMed doi:10.1016/0165-0327(94)90104-X
11. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64(2):161-174. PubMed
12. Matza LS, Rajagopalan KS, Thompson CL, et al. Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. J Clin Psychiatry. 2005;66(11):1432-1440. PubMed
13. Birnbaum HG, Shi L, Dial E, et al. Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis. J Clin Psychiatry. 2003;64(10):1201-1209. PubMed
14. Shi L, Thiebaud P, McCombs JS. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. J Affect Disord. 2004;82(3):373-383. PubMed (Pubitemid 39536169)
15. Nassir Ghaemi S, Miller CJ, Berv DA, et al. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord. 2005;84(2-3):273-277. PubMed doi:10.1016/S0165-0327(03)00196-4
16. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873-1875. PubMed doi:10.1176/appi.ajp.157.11.1873
17. Hirschfeld RM, Holzer C, Calabrese JR, et al. Validity of the Mood Disorder Questionnaire: a general population study. Am J Psychiatry. 2003;160(1):178-180. PubMed doi:10.1176/appi.ajp.160.1.178 (Pubitemid 36042446)
18. Hirschfeld RM, Cass AR, Holt DC, et al. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract. 2005;18(4):233-239. PubMed doi:10.3122/jabfm.18.4.233
19. Eaton WW, Kalaydjian A, Scharfstein DO, et al. Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981-2004. Acta Psychiatr Scand. 2007;116(3):182-188. PubMed doi:10.1111/j.1600-0447.2007.01017.x
20. Cunningham PJ, Kohn L. Health plan switching: choice or circumstance? Health Aff (Millwood). 2000;19(3):158-164. PubMed doi:10.1377/hlthaff.19.3.158
21. Manning JS, Haykal RF, Connor PD, et al. On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry. 1997;38(2):102-108. PubMed doi:10.1016/S0010-440X(97)90089-4
22. Valenstein M, Vijan S, Zeber JE, et al. The cost-utility of screening for depression in primary care. Ann Intern Med. 2001;134(5):345-360. PubMed (Pubitemid 32179474)